Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 10 Startups & Unicorns companies in Liquid biopsy
by Highest Patent Value in the world in 2020

The Liquid biopsy top 10 is Discovery PatSnap’ annual ranking of the top 10 Highest Patent Value Liquid biopsy Startups & Unicorns in the world. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2020, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
A liquid biopsy, also known as fluid biopsy or fluid phase biopsy, is the sampling and analysis of non-solid biological tissue, primarily blood. Like traditional biopsy this type of technique is mainly used as a diagnostic and monitoring tool for diseases such as cancer, with the added benefit of being largely non-invasive. Therefore, it can also be done more frequently which can better track tumors and mutations over a duration of time. It may also be used to validate the efficiency of a cancer treatment drug by taking multiple liquid biopsy samples in the span of a few weeks. The technology may also prove beneficial for patients after treatment to monitor relapse.
#
Company Name
Region
Tech Topics
Total
1
Shanghai Shi, China
Avg patent value: 155,000
2
Genetic testing,Health technology,Health care
Avg patent value: 47,100
3
PHASE Scientific International Ltd.
Hong Kong SAR, China
Avg patent value: 32,000
4
Machine learning,Health care,Clinical trial,
...[+2]
Avg patent value: 22,000
5
QCDx LLC
Avg patent value: 21,500
6
Avg patent value: 20,075
7
Salish Bioscience, Inc
Avg patent value: 20,000
8
Bayern, Germany
Pathology,Health care,Cancer
Avg patent value: 18,000
9
SensID GmbH
Mecklenburg-Vorpommern, Germany
Biology,DNA,Round robin test,
...[+1]
Avg patent value: 5,900
10
Zhejiang Sheng, China
Health care,Drug,Electronic nose,
...[+2]
Avg patent value: 3,600
Page generation time: May 12 2025